Skip to main content
. 2014 Dec 23;9(12):e114585. doi: 10.1371/journal.pone.0114585

Figure 2. Overexpression of miR-503inhibited proliferation of osteosarcoma cells.

Figure 2

(A) qRT-PCR analysis of miR-503 expression after the transfection of miR-503 mimics or scramble or no transfection. (B) The CCK8 assay used to evalute the proliferation of theMG-63 cells after transfection with the miR-503 mimics or scramble or no transfection. (C) RT-PCR analysis of miR-503 expression after the transfection of miR-503inhibitor or control or no transfection. (D) The CCK8 assay used to evalute the proliferation of theMG-63 cells after transfection with the miR-503 inhibitor or control or no transfection. (E) The CCK8 assay used to evalute the proliferation of theU2OScells after transfection with the miR-503 mimics or scramble or no transfection. (F)The CCK8 assay used to evalute the proliferation of theU2OScells after transfection with the miR-503 inhibitor or control or no transfection, *p<0.05, ** p<0.01, and ***p<0.001.